There’s a lot to be optimistic about in the Materials sector as 3 analysts just weighed in on Denison Mines (DNN – Research Report), HEXO (HEXO – Research Report) and Cascades (CADNF – Research Report) with bullish sentiments.
Denison Mines (DNN)
In a report released today, Katie Lachapelle from Canaccord Genuity reiterated a Buy rating on Denison Mines. The company’s shares closed last Friday at $1.34.
According to TipRanks.com, Lachapelle is a top 100 analyst with an average return of
Currently, the analyst consensus on Denison Mines is a Moderate Buy with an average price target of $1.90, which is a 34.8% upside from current levels. In a report issued on September 17, Raymond James also maintained a Buy rating on the stock with a C$2.40 price target.
See today’s analyst top recommended stocks >>
HEXO (HEXO)
CIBC analyst John Zamparo reiterated a Buy rating on HEXO today. The company’s shares closed last Friday at $1.92, close to its 52-week low of $1.86.
According to TipRanks.com, Zamparo is a 3-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for HEXO with a $2.37 average price target.
Cascades (CADNF)
CIBC analyst Hamir Patel reiterated a Buy rating on Cascades today and set a price target of C$18.00. The company’s shares closed last Friday at $12.60.
According to TipRanks.com, Patel is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cascades with a $15.25 average price target, which is a 20.5% upside from current levels. In a report issued on September 14, TD Securities also maintained a Buy rating on the stock with a C$18.50 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DNN:
- Activision Blizzard Stock Crumbles amid Workplace Practice Investigation
- High Tide Named Among Canada’s Fastest-Growing Companies
- Peloton Pedals Backwards: Any Reasons for Optimism?
- 2 ‘Strong Buy’ Dividend Stocks That Insiders Are Snapping Up
- Collegium Pharmaceutical (COLL) Receives a Buy from Needham
